EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer

EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer

Gespeichert in:

Bibliographische Detailangaben
Datum:	2019
Hauptverfasser:	L. M. Kovalevska, L. M. Shlapatska, S. P. Sydorenko, Yu. Lukianova, E. V. Kashuba, V. F. Chekhun
Format:	Artikel
Sprache:	English
Veröffentlicht:	2019
Schriftenreihe:	Oncology
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0001149882
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
von: Kropyvko, S.V., et al.
Veröffentlicht: (2019)

Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
von: Naleskina, L.A., et al.
Veröffentlicht: (2016)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: S. Chekhun, et al.
Veröffentlicht: (2013)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: Chekhun, S., et al.
Veröffentlicht: (2013)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
von: V. F. Chekhun, et al.
Veröffentlicht: (2017)

The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
von: Yu. Lukianova, et al.
Veröffentlicht: (2017)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
von: S. M. Hrybach, et al.
Veröffentlicht: (2018)

Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
von: N. O. Verovkina, et al.
Veröffentlicht: (2017)

Effects of microbiotes on the development of human tumor pathologies
von: V. F. Chekhun, et al.
Veröffentlicht: (2020)

Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
von: L. A. Nalieskina, et al.
Veröffentlicht: (2017)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: O. V. Shepil, et al.
Veröffentlicht: (2014)

The peculiarities of gene expression of medullary breast carcinoma tumor-associated antigensin different types of breast tumors
von: M. A. Shyian, et al.
Veröffentlicht: (2012)

The peculiarities of gene expression of medullary breast carcinoma tumor-associated antigens in different types of breast tumors
von: Shyian, А., et al.
Veröffentlicht: (2012)

A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
von: Shepil, O.V., et al.
Veröffentlicht: (2014)

Features of hepcidin expression in patients with breast cancer
von: Yu. Lukianova, et al.
Veröffentlicht: (2015)

Mutation 6174delt in BRCA2 gene in family with tumor pathology aggregation (clinical case)
von: O. V. Paliichuk, et al.
Veröffentlicht: (2015)

Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects
von: Cherdyntseva, N.V., et al.
Veröffentlicht: (2017)

Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
von: Kryzhanivska, A.E., et al.
Veröffentlicht: (2018)

Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
von: Zavyalova, M., et al.
Veröffentlicht: (2016)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: S. V. Chekhun, et al.
Veröffentlicht: (2015)

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: Chekhun, S.V., et al.
Veröffentlicht: (2015)

Chemocine receptor CXCR4 expression and microvessels density in malignant tumors of the breast of patients with sings of metabolic syndrome
von: N. P. Yurchenko, et al.
Veröffentlicht: (2020)

Expression of drug resistance proteins in triple-receptor-negative tumors as the basis of individualized therapy of the breast cancer patients
von: Chekhun, V.F., et al.
Veröffentlicht: (2009)

Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
von: L. A. Nalieskina, et al.
Veröffentlicht: (2018)

Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles
von: Gerashchenko, T.S., et al.
Veröffentlicht: (2018)

Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles
von: Gerashchenko, T.S., et al.
Veröffentlicht: (2018)

Expression analisis of the ITSN2 and TKS5 mRNA isoforms in human malignant breast tumors
von: S. V. Kropyvko, et al.
Veröffentlicht: (2018)

Peculiarity of the expression of IL-10 in connection with some factors of the tumor microenvironment and the clinical course of gastric cancer
von: L. D. Humeniuk, et al.
Veröffentlicht: (2017)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
von: Bereznaya, N.M., et al.
Veröffentlicht: (2008)

Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
von: V. F. Chekhun, et al.
Veröffentlicht: (2016)

Clinical significance of hormonal receptor status of malignant ovarian tumors
von: I. G. Tkalia, et al.
Veröffentlicht: (2014)

Clinical significance of hormonal receptor status of malignant ovarian tumors
von: Tkalia, I.G., et al.
Veröffentlicht: (2014)

Cutaneous leiomyosarcoma: a clinical, dermoscopic, pathologic case study
von: Giorgi, V. De, et al.
Veröffentlicht: (2023)

Is there any association BETWEEN TACSTD2, KIAA1253, Ku70 and mutant kras gene expression and clinical-pathological features of colorectal cancer?
von: Ghezzi, T.L., et al.
Veröffentlicht: (2011)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2016)